Annual Total Long Term Liabilities
$35.75 M
+$6.08 M+20.49%
31 December 2023
Summary:
Abeona Therapeutics annual total long term liabilities is currently $35.75 million, with the most recent change of +$6.08 million (+20.49%) on 31 December 2023. During the last 3 years, it has risen by +$15.16 million (+73.61%). ABEO annual total long term liabilities is now at all-time high.ABEO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$56.40 M
+$12.48 M+28.41%
30 September 2024
Summary:
Abeona Therapeutics quarterly total long term liabilities is currently $56.40 million, with the most recent change of +$12.48 million (+28.41%) on 30 September 2024. Over the past year, it has increased by +$20.64 million (+57.74%). ABEO quarterly long term liabilities is now -21.47% below its all-time high of $71.82 million, reached on 31 March 2024.ABEO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABEO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +57.7% |
| 3 y3 years | +73.6% | +173.8% |
| 5 y5 years | +472.0% | +802.2% |
ABEO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +73.6% | -21.5% | +424.7% |
| 5 y | 5 years | at high | +472.0% | -21.5% | +1094.3% |
| alltime | all time | at high | >+9999.0% | -21.5% |
Abeona Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $56.40 M(+28.4%) |
| June 2024 | - | $43.92 M(-38.8%) |
| Mar 2024 | - | $71.82 M(+100.9%) |
| Dec 2023 | $35.75 M(+20.5%) | $35.75 M(+0.3%) |
| Sept 2023 | - | $35.64 M(+2.5%) |
| June 2023 | - | $34.77 M(+27.9%) |
| Mar 2023 | - | $27.18 M(-8.4%) |
| Dec 2022 | $29.67 M(+44.1%) | $29.67 M(+176.1%) |
| Sept 2022 | - | $10.75 M(-1.8%) |
| June 2022 | - | $10.95 M(-3.9%) |
| Mar 2022 | - | $11.39 M(-44.7%) |
| Dec 2021 | $20.59 M(+207.9%) | $20.59 M(+60.9%) |
| Sept 2021 | - | $12.80 M(+171.1%) |
| June 2021 | - | $4.72 M(-23.9%) |
| Mar 2021 | - | $6.20 M(-7.3%) |
| Dec 2020 | $6.69 M(+7.0%) | $6.69 M(+21.2%) |
| Sept 2020 | - | $5.52 M(-4.4%) |
| June 2020 | - | $5.77 M(-4.1%) |
| Mar 2020 | - | $6.01 M(-3.8%) |
| Dec 2019 | $6.25 M(-68.7%) | $6.25 M(-76.4%) |
| Sept 2019 | - | $26.48 M(-0.8%) |
| June 2019 | - | $26.71 M(-0.8%) |
| Mar 2019 | - | $26.93 M(+34.6%) |
| Dec 2018 | $20.00 M(+553.4%) | $20.00 M(>+9900.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $3.06 M(-16.5%) | $3.06 M(-4.7%) |
| Sept 2017 | - | $3.21 M(-4.5%) |
| June 2017 | - | $3.36 M(-4.3%) |
| Mar 2017 | - | $3.51 M(-4.1%) |
| Dec 2016 | $3.66 M(-66.3%) | $3.66 M(-3.9%) |
| Sept 2016 | - | $3.81 M(-3.8%) |
| June 2016 | - | $3.96 M(-3.6%) |
| Mar 2016 | - | $4.12 M(-62.1%) |
| Dec 2015 | $10.86 M(+22.4%) | $10.86 M(-27.2%) |
| Sept 2015 | - | $14.91 M(-1.0%) |
| June 2015 | - | $15.06 M(+72.7%) |
| Mar 2015 | - | $8.72 M(-1.7%) |
| Dec 2014 | $8.87 M(+37.9%) | $8.87 M(-50.8%) |
| Sept 2014 | - | $18.02 M(+3.1%) |
| June 2014 | - | $17.47 M(+194.8%) |
| Mar 2014 | - | $5.93 M(-7.8%) |
| Dec 2013 | $6.43 M(-47.2%) | $6.43 M(+3.0%) |
| Sept 2013 | - | $6.25 M(-10.5%) |
| June 2013 | - | $6.98 M(-8.0%) |
| Mar 2013 | - | $7.58 M(-37.7%) |
| Dec 2012 | $12.18 M(+32.3%) | $12.18 M(-68.4%) |
| Sept 2012 | - | $38.54 M(+98.0%) |
| June 2012 | - | $19.46 M(+86.2%) |
| Mar 2012 | - | $10.45 M(+13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $9.20 M(-39.9%) | $9.20 M(-19.4%) |
| Sept 2011 | - | $11.42 M(-29.2%) |
| June 2011 | - | $16.13 M(+8.9%) |
| Mar 2011 | - | $14.81 M(-3.3%) |
| Dec 2010 | $15.31 M(-23.2%) | $15.31 M(-16.1%) |
| Sept 2010 | - | $18.25 M(+34.9%) |
| June 2010 | - | $13.53 M(-20.3%) |
| Mar 2010 | - | $16.98 M(-14.9%) |
| Dec 2009 | $19.94 M(+157.4%) | $19.94 M(+93.3%) |
| Sept 2009 | - | $10.31 M(+14.2%) |
| June 2009 | - | $9.03 M(-1.0%) |
| Mar 2009 | - | $9.12 M(+17.8%) |
| Dec 2008 | $7.75 M(+20.8%) | $7.75 M(-0.5%) |
| Sept 2008 | - | $7.79 M(+5.1%) |
| June 2008 | - | $7.41 M(+15.8%) |
| Mar 2008 | - | $6.39 M(-0.3%) |
| Dec 2007 | $6.41 M(+16.5%) | $6.41 M(+16.5%) |
| Sept 2007 | - | $5.50 M(0.0%) |
| June 2007 | - | $5.50 M(0.0%) |
| Mar 2007 | - | $5.50 M(0.0%) |
| Dec 2006 | $5.50 M(-28.0%) | $5.50 M(0.0%) |
| Sept 2006 | - | $5.50 M(0.0%) |
| June 2006 | - | $5.50 M(-31.2%) |
| Mar 2006 | - | $7.99 M(+4.7%) |
| Dec 2005 | $7.64 M(+6.1%) | $7.64 M(-20.1%) |
| Sept 2005 | - | $9.55 M(+70.2%) |
| June 2005 | - | $5.61 M(-0.7%) |
| Mar 2005 | - | $5.65 M(-21.5%) |
| Dec 2004 | $7.20 M(-48.7%) | $7.20 M(+26.2%) |
| Sept 2004 | - | $5.70 M(-58.6%) |
| June 2004 | - | $13.78 M(-0.8%) |
| Mar 2004 | - | $13.88 M(-1.0%) |
| Dec 2003 | $14.02 M(-1.5%) | $14.02 M(+0.2%) |
| Sept 2003 | - | $13.99 M(-0.1%) |
| June 2003 | - | $14.01 M(-0.1%) |
| Mar 2003 | - | $14.03 M(-1.4%) |
| Dec 2002 | $14.23 M(+1.7%) | $14.23 M(+0.1%) |
| Sept 2002 | - | $14.22 M(-0.2%) |
| June 2002 | - | $14.24 M(-0.2%) |
| Mar 2002 | - | $14.27 M(+2.0%) |
| Dec 2001 | $14.00 M(+3.5%) | $14.00 M(-0.2%) |
| Sept 2001 | - | $14.03 M(+3.7%) |
| June 2001 | - | $13.53 M(0.0%) |
| Mar 2001 | - | $13.53 M(0.0%) |
| Dec 2000 | $13.53 M(>+9900.0%) | $13.53 M(0.0%) |
| Sept 2000 | - | $13.53 M(>+9900.0%) |
| June 1999 | - | $3000.00(-62.5%) |
| Mar 1999 | - | $8000.00 |
| Dec 1998 | $100.00 K(-29.6%) | - |
| Dec 1997 | $142.00 K(-26.4%) | - |
| Dec 1996 | $193.00 K(+2657.1%) | - |
| Dec 1995 | $7000.00 | - |
FAQ
- What is Abeona Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly long term liabilities year-on-year change?
What is Abeona Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ABEO is $35.75 M
What is the all time high annual total long term liabilities for Abeona Therapeutics?
Abeona Therapeutics all-time high annual total long term liabilities is $35.75 M
What is Abeona Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ABEO is $56.40 M
What is the all time high quarterly long term liabilities for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly total long term liabilities is $71.82 M
What is Abeona Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ABEO quarterly total long term liabilities has changed by +$20.64 M (+57.74%)